Omnicell
About
Pharmacy automation and medication management company — NASDAQ: OMCL, ~$950M revenue. Omnicell ONE is the intelligent pharmacy platform integrating automated dispensing cabinets (XT series), central pharmacy robots (XR2 Automated Pharmacy), IV compounding, and medication adherence packaging for retail and outpatient pharmacy. Used by 7,000+ hospitals and pharmacies globally. XR2 Automated Pharmacy is a central pharmacy robot that automates 90%+ of medication dispensing in central pharmacy, drama...
Details
VenSearch Intelligence
Ideal Customer
- Omnicell's primary sweet spot is large enterprise health systems and integrated delivery networks — specifically acute-care hospitals with high medication volumes, multiple nursing units, and central pharmacy operations where automation delivers the greatest ROI on labor reduction and patient safety.
- Its installed customer base is skewed toward mid-to-large hospital systems (typically with 200+ beds and multiple facilities), including major academic medical centers, regional health networks, and national hospital chains.
Key Differentiators
- Omnicell's core differentiator is its end-to-end 'Autonomous Pharmacy' platform vision — the only vendor in the industry claiming both a HITRUST-certified cloud platform (OmniSphere) and a HITRUST-certified suite of medication management hardware (XT Series, XR2), making it uniquely positioned for security-conscious enterprise health systems.
- Its XR2 robotic dispensing system reports 99.9% picking accuracy, and the company competes with BD's Pyxis through a strategy of deeper enterprise software, cloud-based inventory analytics, and broader workflow integration rather than just cabinet hardware.
Industries Served
- Omnicell exclusively serves the healthcare industry, with no material presence in financial services, legal, education, or other verticals.
- Its core markets are acute-care hospitals and integrated delivery networks (IDNs), but it also serves outpatient and ambulatory settings, retail and independent community pharmacies, long-term care and post-acute facilities, specialty pharmacies, and 340B-eligible covered entities such as federally qualified health centers.
Service Coverage
- Omnicell operates primarily in the United States, which represented 91% of its total revenues for fiscal year 2024, with the remaining 9% coming from international markets.
- The company maintains office locations across the U.S. (Fort Worth HQ, Austin, Pennsylvania, Florida, California, Texas) and internationally in Australia, China, France, Germany, India, Italy, the Netherlands, the UAE, and the United Kingdom, with distribution also reaching the Middle East, Asia, and Latin America through reseller partners.
Partnerships
- Omnicell has formally published interoperability integrations with Epic and Cerner (Oracle Health), the two dominant EHR vendors in the U.S. hospital market, enabling closed-loop medication administration workflows directly within EHR environments.
- Its OmniSphere cloud platform is hosted on Amazon Web Services (AWS), leveraging that infrastructure for all cloud-native solutions including Inventory Optimization Service, Essentials, and Telemetry Services.
Company Size & Ownership
- Omnicell was founded in September 1992 by Randall A. Lipps and went public on Nasdaq (OMCL) via IPO in August 2001.
- The company employs approximately 3,670 people as of 2024 and reported total revenues of approximately $1.112 billion in fiscal 2024 and $1.185 billion in fiscal 2025.
Compliance & Certifications
- Omnicell holds dual HITRUST CSF i1 certifications — one for its core medication management solutions (including XT, XR2, and OmniCenter platform-based products) and a second, received in June 2025, for its OmniSphere cloud-native platform hosted on Amazon Web Services.
- Omnicell claims to be the only vendor in the pharmacy automation industry with both a certified cloud platform and a certified suite of medication management products under HITRUST, which is widely considered the gold standard for healthcare cybersecurity and incorporates HIPAA, NIST, ISO, and other frameworks.
Compiled from public sources by VenSearch · Last researched October 14, 2026
Offerings
2 offeringsOmnicell XT Automated Dispensing Cabinets
Bedside medication dispensing for hospital nursing units — XT series ADCs store controlled substances and unit-dose medications with biometric access control, real-time inventory tracking, and EHR integration for closed-loop medication administration. Omnicell ONE Intelligence software provides predictive restocking and medication waste analytics.
XR2 Automated Pharmacy
Central pharmacy robot for high-volume medication dispensing — XR2 automates 90%+ of central pharmacy unit-dose dispensing, including patient-specific labeling, barcode verification, and pneumatic tube delivery. Reduces pharmacist dispensing labor by 50-70%, freeing pharmacists for clinical consultation and patient safety activities.
Considering Omnicell?
Our team will work with you to determine if Omnicell is the right fit for your organization. From research and assessment through procurement negotiation and ongoing vendor management — we handle the entire process at no cost to you.